| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3694838
Max Phase: Preclinical
Molecular Formula: C17H23N5
Molecular Weight: 297.41
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Nc1nccc(N2CCCN(Cc3ccccc3)CCC2)n1
Standard InChI: InChI=1S/C17H23N5/c18-17-19-9-8-16(20-17)22-12-4-10-21(11-5-13-22)14-15-6-2-1-3-7-15/h1-3,6-9H,4-5,10-14H2,(H2,18,19,20)
Standard InChI Key: FCVGQACZWWDJJA-UHFFFAOYSA-N
Associated Targets(Human)
Histamine H3 receptor 10389 Activities
Associated Targets(non-human)
Histamine H3 receptor 2579 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 297.41 | Molecular Weight (Monoisotopic): 297.1953 | AlogP: 2.16 | #Rotatable Bonds: 3 |
| Polar Surface Area: 58.28 | Molecular Species: BASE | HBA: 5 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 9.13 | CX LogP: 2.29 | CX LogD: 0.36 |
| Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.94 | Np Likeness Score: -1.47 |
References
| 1. (2014) 4-substituted-2-amino-pyrimidine derivatives, |
Source
Source(1):